16:02 Dec 20
Glenmark Life Sciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Glenmark Life Sciences Ltd.
Industry Pharmaceuticals
16:02 Dec 20
Quality
45/100
Medium Financial Strength
Valuation
34/100
Mid Valuation
Technical
46/100
Technically Neutral
Strength
6
Weakness
10
Opportunity
1
Threats
0
12.42K
Market Cap (Cr)
29.32
PE Ratio
4.89
Price to Book Ratio
40.88
RSI
0.00 %
Net Profit Margin
Download Our App On:
